Optimizing oral contraceptive timing: Daytime intake reduces doses and enhances efficacy
Brenda Lyn Gavina, Taeyong Lee, Olive Cawiding, Sunhwa Choi, Sungwook Choi, Soyoung Kim, Jae Kyoung Kim, Marc Birtwistle, Marc Birtwistle, Marc Birtwistle, Marc Birtwistle, Marc Birtwistle
TL;DR
Taking oral contraceptives during the day instead of the evening can reduce hormone doses and improve effectiveness by aligning with the body's natural hormone cycles.
Contribution
A mathematical model integrating circadian rhythms with contraceptive pharmacokinetics to optimize dosing timing and regimen.
Findings
Daytime OC dosing reduces ethinyl estradiol and dienogest doses by aligning with luteinizing hormone production peaks.
An optimal nonconstant regimen lowers ethinyl estradiol doses by 67% and reduces intake days from 21 to 8 per cycle.
Incorporating circadian rhythms in OC timing enhances safety and efficacy while reducing adverse event risks.
Abstract
Contraception is essential for reproductive health and women’s empowerment because it allows informed choices about pregnancy prevention. Oral contraceptives (OCs) are a popular method due to their accessibility and high level of effectiveness in attaining contraception through the suppression of ovulation. However, current OC regimens do not consider circadian hormonal rhythms, which significantly influence hormone secretion and drug metabolism. Accounting for circadian rhythms may further reduce the dosage of current formulations, which pose risks, including an increased likelihood of venous thromboembolism. We addressed this gap by developing a mathematical model that integrates circadian rhythms with contraceptive pharmacokinetics. Our results show that daytime OC dosing reduces the required ethinyl estradiol (EE) dose by about 6% and the required dienogest (DNG) dose by about 52%…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
Figure 17
Figure 18
Figure 19
Figure 20
Figure 21
Figure 22
Figure 23
Figure 24
Figure 25
Figure 26
Figure 27
Figure 28
Figure 29
Figure 30
Figure 31
Figure 32
Figure 33
Figure 34
Figure 35
Figure 36
Figure 37
Figure 38
Figure 39
Figure 40
Figure 41
Figure 42
Figure 43
Figure 44
Figure 45
Figure 46
Figure 47
Figure 48
Figure 49
Figure 50Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsReproductive Health and Contraception · Menstrual Health and Disorders · Menopause: Health Impacts and Treatments